🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
120 Servings
Botanical Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

Coptis chinensis
200 mg
📊 Market median: 400.0mg (380 products) 📚 34 studies (Tier A: 1, B: 10)
This product: 150mg
📊 Market median: 400.0mg (380 products) 📚 34 studies (Tier A: 1, B: 10)
This product: 150mg
Andrographis paniculata
100 mg

Other Ingredients

Gelatin Water, Purified

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (74% of products) Nutrient (3% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Recommendations: Take one (1) capsule twice daily, or as directed by your Longevity physician.

⚠️ Warnings & Precautions

Tamper evident. Do not use if seal is broken.

Consult your physician if you are pregnant or breastfeeding before using this product.

Keep out of reach of children.

🧪 Formulation Notes

The unique blend of powerful immune-supporting herbal extracts in this formula promotes the body's natural defenses through various mechanisms. Standardized extracts of two echinacea species support macrophages and aid in healthy antibody production to promote a healthy immune response. Andrographolides in Andrographis provide immune and respiratory support properties. Berberine, a major alkaloid found in Coptis chinensis, not only has direct immune-supporting activity, but also supports healthy blood sugar metabolism, fat metabolism, and cardiovascular function.

Additional Information

Store in a cool dry place.

Order: 866-66-YOUNG, LMClinic.com

Product Details

DSLD Entry Date 2024-05-23
Product Type Botanical
Form Capsule
DSLD ID 308015
Data Updated 2026-04-11

Research Evidence

38 Research Sources
52 Avg Quality Score
15 Meta Analysis
12 Systematic Review
6 Rct
2 Clinical Trial
1 Regulatory Source
1 Openfda Safety
A Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2014
B Efficacy and safety of Echinacea purpurea in treating upper respiratory infections and complications of otitis media in children: Systematic review and meta-analysis
Meta Analysis Clinical nutrition ESPEN 2025
B Echinacea for preventing and treating the common cold
Systematic Review The Cochrane database of systematic reviews 2000
B Echinacea Supplementation Does Not Impact Aerobic Capacity and Erythropoiesis in Athletes: A Meta-Analysis
Meta Analysis Nutrients 2024
B Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2006
B Therapeutic Potential of a Natural Blend of Aronia melancarpa, Lonicera caerulea, and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights
Rct International journal of molecular sciences 2024
B Herbal Medicine in Children With Respiratory Tract Infection: Systematic Review and Meta-Analysis
Meta Analysis Academic pediatrics 2018
B Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis
Meta Analysis The Lancet. Infectious diseases 2007
B Herbal Medicine for Cough: a Systematic Review and Meta-Analysis
Meta Analysis Forschende Komplementarmedizin (2006) 2015
B Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis
Meta Analysis Complementary therapies in medicine 2019
View all evidence for Echinacea →

Compare Similar Products

View all Echinacea products →